Gateway Investment Advisers’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$706K Sell
9,429
-10,175
-52% -$806K 0.01% 604
2026
Q2
$1.55M Buy
19,604
+14,393
+276% +$1.22M 0.02% 339
2026
Q1
$449K Buy
+5,211
New +$468K 0.01% 516

Other funds holding GMED

Gateway Investment Advisers's GMED Position: Q3 2026 in Review

Gateway Investment Advisers reduced its Globus Medical (GMED) stake by 52% in Q3 2026, selling an estimated $806K and leaving 9,429 shares worth $706K. The position accounts for 0.01% of the portfolio, ranked #604.

Gateway Investment Advisers first reported a position in GMED in Q1 2026 and has held it in 3 quarters since. The position peaked at $1.55M in Q2 2026. 49 funds tracked by Wall St. Rank hold GMED as of Q3 2026.

  • Gateway Investment Advisers held 9,429 shares of Globus Medical worth $706K as of Q3 2026.
  • Gateway Investment Advisers sold 10,175 Globus Medical shares in Q3 2026, an estimated $806K.
  • Globus Medical made up 0.01% of Gateway Investment Advisers's portfolio in Q3 2026, its #604 holding.
  • Gateway Investment Advisers first reported a position in Globus Medical in Q1 2026 and has held it in 3 quarters since.
  • Gateway Investment Advisers's Globus Medical position peaked at $1.55M in Q2 2026.
  • 49 funds tracked by Wall St. Rank held Globus Medical as of Q3 2026.

Based on Gateway Investment Advisers's 13F filing for Q3 2026, filed 13 Oct 2026.